Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults
- 8 May 2007
- Vol. 25, A101-A107
- https://doi.org/10.1016/j.vaccine.2007.04.050
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Recent developments in Neisseria meningitidis group A conjugate vaccinesExpert Opinion on Biological Therapy, 2005
- Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in EnglandClinical and Vaccine Immunology, 2003
- Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countriesThe Lancet, 2003
- A Critical Review of Control Strategies against Meningococcal Meningitis Epidemics in Sub-Saharan African CountriesInfection, 2002
- Meningococcal DiseaseNew England Journal of Medicine, 2001
- Serological Basis for Use of Meningococcal Serogroup C Conjugate Vaccines in the United Kingdom: Reevaluation of Correlates of ProtectionInfection and Immunity, 2001
- Evaluation of meningococcal meningitis vaccination strategies for the meningitis belt in AfricaThe Pediatric Infectious Disease Journal, 1999
- Meningococcal meningitis in AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Age-Specific Prevalence of Antibodies to Hepatitis A and E Viruses in Pune, India, 1982 and 1992The Journal of Infectious Diseases, 1995
- Spectrum of hepatitis E virus infection in IndiaJournal of Medical Virology, 1994